In a case that could have significant ramifications for the scope of the US False Claims Act, the US Supreme Court has agreed to remand for further proceedings allegations that supermarket and pharmacy chains defrauded the government via low-cost drug programs.
Tracing its roots back to Basel in the late nineteenth century, Sandoz has confirmed the location of its new planned permanent headquarters post-spin.
Coherus BioSciences had teased a “compelling value proposition” for its Yusimry (adalimumab-aqvh) biosimilar to AbbVie’s Humira blockbuster and it has delivered, with a pair of pricing strategies include one though an alliance with self-labelled “disruptor” Mark Cuban.
Generics Bulletin previews the most notable and anticipated events for June 2023.
The US Supreme Court has breathed new life into a consolidated pair of whistleblower lawsuits claiming that the US supermarket and pharmacy chains SuperValu and Safeway defrauded the US government by hundreds of millions of dollars via low-cost drug programs, including generic programs.
US Supreme Court Justice Clarence Thomas, writing the opinion for a unanimous court, vacated favorable judgments from the US Court of Appeals for the Seventh Circuit, and ruled that they be...
Unfortunately, Gregg Phillips’ claims that he was twice teleported from one place to another aren’t the biggest problems for this top government official with a long history of shady deals, charit...